SYNCOM FORMULATIONS (INDIA)
Back to All Ratios
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Working Capital/Sales History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Working Capital/Sales(x) | 2.21 | 1.57 | 3.27 | 3.57 | 6.67 |
What is the latest Working Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Working Capital/Sales |
|---|---|
| Mar2025 | 2.21 |
| Mar2024 | 1.57 |
| Mar2023 | 3.27 |
| Mar2022 | 3.57 |
| Mar2017 | 6.67 |
How is Working Capital/Sales of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Working Capital/Sales | % Change | |
|---|---|---|---|
| Mar2025 | 2.21 | 40.76 | |
| Mar2024 | 1.57 | -51.99 | |
| Mar2023 | 3.27 | -8.40 | |
| Mar2022 | 3.57 | -46.48 | |
| Mar2017 | 6.67 | - | |
Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Working Capital/Sales ratio of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,468.3 Cr | -3% | -6.2% | -21.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,102.0 Cr | -0.7% | 4.3% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,299.0 Cr | -0.6% | -2.6% | 6.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,753.0 Cr | 0.4% | 4.7% | 19.8% | Stock Analytics | |
| CIPLA | ₹121,735.0 Cr | -1.3% | -4.8% | 2.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,155.0 Cr | -1.1% | -3.7% | 2.5% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -3% |
-6.2% |
-21.7% |
| SENSEX | -0.1% |
0% |
9% |
You may also like the below Video Courses